Literature DB >> 3492971

Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.

A E Bedwell, C J Elson, S D Carter, P A Dieppe, C W Hutton, R Czudek.   

Abstract

The complement activating aggregates in synovial fluids of patients with rheumatoid arthritis (RA) have been isolated using monoclonal IgM anti-C3d antibodies attached to solid phases, and the content of the material bound has been analysed. High levels of aggregated IgG bearing C3d were found in RA synovial fluids, and IgG was the major immunoglobulin bound from such synovial fluids by anti-C3d Sepharose. A strong correlation was shown between levels of aggregated IgG bearing C3d and complement activation, as judged by C3d levels. Significant (but less strong) relationships were also observed between C3d levels and both complement consuming and C1q binding activity. C3d levels and levels of aggregated IgG bearing C3d were both significantly associated with the numbers of polymorphonuclear leucocytes (PMNs) found in RA synovial fluids. From these results it is concluded that the aggregated immunoglobulins bearing C3d (particularly IgG) isolated from RA synovial fluids are responsible for activating complement and attracting PMNs into the joint space. Radioimmunoassay showed no correlation, however, between levels of aggregated IgG (or IgM) bearing C3d and rheumatoid factor (RF) activity bound by anti-C3d. In addition, the material bound by anti-C3d Sepharose from most synovial fluid polyethylene glycol precipitates did not contain either IgM or IgG RF. Thus both techniques show that the majority of complexes bearing C3d do not contain RF. As the complement fixing aggregates apparently contain only immunoglobulin and complement components the results raise the problem of how the aggregates are formed. It is suggested that RA IgG may remain aggregated after either antigen or antibody (RF) has dissociated from the complex.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3492971      PMCID: PMC1002059          DOI: 10.1136/ard.46.1.55

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  43 in total

1.  Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

Authors:  L H Perrin; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

Review 2.  Membrane complement receptors specific for bound fragments of C3.

Authors:  G D Ross; M E Medof
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

Review 3.  The immunopathology of joint inflammation in rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

4.  Metabolism of radio-labelled C3: effects of in vivo activation in rabbits.

Authors:  J A Charlesworth; D G Williams; P Naish; P J Lachmann; D K Peters
Journal:  Clin Exp Immunol       Date:  1974-03       Impact factor: 4.330

5.  Complement-fixing activity of rheumatoid synovial fluid.

Authors:  A S Townes; R L Marcus
Journal:  Ann Rheum Dis       Date:  1972-09       Impact factor: 19.103

6.  Studies of the third component of complement in synovial fluid from arthritic patients. II. Conversion and its relation to total complement.

Authors:  H Hedberg; B Lundh; A B Laurell
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

7.  Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels.

Authors:  R J Winchester; V Agnello; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

8.  The complement system in rheumatoid synovitis. I. An analysis of complement component activities in rheumatoid synovial fluids.

Authors:  S Ruddy; K F Austen
Journal:  Arthritis Rheum       Date:  1970 Nov-Dec

9.  Breakdown products of C 3 in human synovial fluids.

Authors:  N J Zvaifler
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

10.  Complement fixation by rheumatoid factor.

Authors:  K Tanimoto; N R Cooper; J S Johnson; J H Vaughan
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

View more
  11 in total

1.  A quantitative lateral flow assay to detect complement activation in blood.

Authors:  Elizabeth C Schramm; Nick R Staten; Zhouning Zhang; Samuel S Bruce; Christopher Kellner; John P Atkinson; Vasileios C Kyttaris; George C Tsokos; Michelle Petri; E Sander Connolly; Paul K Olson
Journal:  Anal Biochem       Date:  2015-02-04       Impact factor: 3.365

2.  Immunoglobulin isotype composition of circulating and intra-articular immune complexes in patients with inflammatory joint disease.

Authors:  A D Crockard; J M Thompson; M B Finch; T A McNeill; A L Bell; S D Roberts
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

3.  Concentrations of glycosaminoglycans in synovial fluids and their relation with immunological and inflammatory mediators in rheumatoid arthritis.

Authors:  A Bensouyad; A P Hollander; B Dularay; A E Bedwell; R A Cooper; C W Hutton; P A Dieppe; C J Elson
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

4.  Angioimmunoblastic lymphadenopathy.

Authors:  P Emery; G S Panayi
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103

Review 5.  Rheumatoid factors in immune complexes of patients with rheumatoid arthritis.

Authors:  M Mannik; F A Nardella; E H Sasso
Journal:  Springer Semin Immunopathol       Date:  1988

6.  Oxidative response of polymorphonuclear leucocytes to synovial fluids from patients with rheumatoid arthritis.

Authors:  B Dularay; J S Badesha; P A Dieppe; C J Elson
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

7.  Depressed degranulation response of synovial fluid polymorphonuclear leucocytes from patients with rheumatoid arthritis to IgG aggregates.

Authors:  B Dularay; P A Dieppe; C J Elson
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

8.  Complement Receptor 2 Based Immunoassay Measuring Activation of the Complement System at C3-Level in Plasma Samples From Mice and Humans.

Authors:  Lene Halkjær; Anne Troldborg; Henrik Pedersen; Lisbeth Jensen; Annette Gudmann Hansen; Troels Krarup Hansen; Mette Bjerre; Jakob Appel Østergaard; Steffen Thiel
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

Review 9.  Citrullination in Rheumatoid Arthritis-A Process Promoted by Neutrophil Lysis?

Authors:  Tal Gazitt; Christian Lood; Keith B Elkon
Journal:  Rambam Maimonides Med J       Date:  2016-10-31

Review 10.  Complement in the Initiation and Evolution of Rheumatoid Arthritis.

Authors:  V Michael Holers; Nirmal K Banda
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.